Filing Details
- Accession Number:
- 0001628280-23-018931
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-05-18 19:18:04
- Reporting Period:
- 2023-05-09
- Accepted Time:
- 2023-05-18 19:18:04
- Original Submission Date:
- 2023-05-10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551306 | Progyny Inc. | PGNY | Services-Misc Health & Allied Services, Nec (8090) | 272220139 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1576147 | Peter Anevski | C/O Progyny, Inc. 1359 Broadway, 2Nd Floor New York NY 10018 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-05-09 | 6,095 | $37.61 | 71,318 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2023-05-09 | 1,568 | $38.24 | 69,750 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 6, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.05 to $38.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The amount reported in Column 5 of Table I reflects the number of shares of common stock indirectly held by the Reporting Person as of the date of the original Form 4 filing on May 10, 2023.